-
EP1278743
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1278743
| EP1278743 - NOVEL ANTI-INFECTIVES [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 24.03.2006 Database last updated on 03.09.2024 | Most recent event Tooltip | 24.03.2006 | Application deemed to be withdrawn | published on 10.05.2006 [2006/19] | Applicant(s) | For all designated states SMITHKLINE BEECHAM CORPORATION One Franklin Plaza Philadelphia, PA 19103 / US | [N/P] |
| Former [2003/05] | For all designated states SmithKline Beecham Corporation One Franklin Plaza Philadelphia, PA 19103 / US | Inventor(s) | 01 /
DHANAK, Dashyant 1250 South Collegeville Road Collegeville, PA 19426 / US | 02 /
CARR, Thomas 1250 South Collegeville Road Collegeville, PA 19426 / US | [2003/05] | Representative(s) | Crawley, Karen Anne GlaxoSmithKline Global Patents (CN925.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB | [N/P] |
| Former [2003/05] | Crawley, Karen Anne GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB | Application number, filing date | 01933049.7 | 04.05.2001 | [2003/05] | WO2001US14525 | Priority number, date | US20000201945P | 05.05.2000 Original published format: US 201945 P | [2003/05] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO0185720 | Date: | 15.11.2001 | Language: | EN | [2001/46] | Type: | A1 Application with search report | No.: | EP1278743 | Date: | 29.01.2003 | Language: | EN | The application published by WIPO in one of the EPO official languages on 15.11.2001 takes the place of the publication of the European patent application. | [2003/05] | Search report(s) | International search report - published on: | US | 15.11.2001 | (Supplementary) European search report - dispatched on: | EP | 27.03.2003 | Classification | IPC: | A61K31/40, C07D409/04, C07D207/16, C07D409/14, C07D405/04, C07D405/14, C07D417/04, C07D417/14, A61K31/427, A61K31/4025 | [2003/20] | CPC: |
C07D401/04 (EP,US);
A61P1/16 (EP);
A61P31/00 (EP);
A61P31/14 (EP);
C07D207/16 (EP,US);
C07D405/04 (EP,US);
C07D405/14 (EP,US);
C07D409/04 (EP,US);
C07D409/14 (EP,US);
C07D417/04 (EP,US)
(-)
|
| Former IPC [2003/05] | C07D409/00, C07D207/00, A61K31/40 | Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2003/05] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | SI | Not yet paid | Title | German: | NEUE ANTIINFEKTIÖSE WIRKSTOFFE | [2003/05] | English: | NOVEL ANTI-INFECTIVES | [2003/05] | French: | NOUVEAUX ANTI-INFECTIEUX | [2003/05] | Entry into regional phase | 06.11.2002 | National basic fee paid | 06.11.2002 | Search fee paid | 06.11.2002 | Designation fee(s) paid | 06.11.2002 | Examination fee paid | Examination procedure | 04.12.2001 | Request for preliminary examination filed International Preliminary Examining Authority: US | 06.11.2002 | Amendment by applicant (claims and/or description) | 06.11.2002 | Examination requested [2003/05] | 17.01.2005 | Despatch of a communication from the examining division (Time limit: M04) | 06.05.2005 | Reply to a communication from the examining division | 21.06.2005 | Despatch of a communication from the examining division (Time limit: M04) | 03.11.2005 | Application deemed to be withdrawn, date of legal effect [2006/19] | 06.12.2005 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2006/19] | Fees paid | Renewal fee | 07.05.2003 | Renewal fee patent year 03 | 05.05.2004 | Renewal fee patent year 04 | 13.05.2005 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO0009543 (BOEHRINGER INGELHEIM CA LTD [CA], et al) [A] 1-11 * the whole document *; | [A] - HAN W ET AL, "alpha-Ketoamides, alpha-ketoesters and alpha-diketones as HCV NS3 protease inhibitors", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, (200004), vol. 10, no. 8, ISSN 0960-894X, pages 711 - 713, XP004203480 [A] 1-11 * the whole document * DOI: http://dx.doi.org/10.1016/S0960-894X(00)00074-3 | International search | [AE]US6239150 (OSHIMA MASAHIRO [JP], et al) |